Radiosynovectomy's clinical applications and cost effectiveness: A review
References (40)
- et al.
Arthroscropic synovectomy of the knee for rheumatoid arthritis
Arthroscopy
(1991) - et al.
Radiation synovectomy with Dy-165-FhMA: Lymph node uptake and radiation dosimetry calculations
Int J Nucl Med Biol
(1986) - et al.
Treatment of rheumatoid arthritis using radiopharmaceuticals
Int J Rad Appl Instrum (B)
(1987) Possibilities and dangers of chemical synovectomy
Hippokrates
(1971)- et al.
Intra-articular thio-tepa compared with depo-medrol and procaine in the treatment of arthritis
J Bone Joint Surg Am
(1970) - et al.
Synoviorthesis with colloidal P-32 chromic phosphate for hemophilic arthropathy: Clinical follow-up
Arch Phys Med Rehabil
(1985) - et al.
Open and arthroscopic synovectomy in hemophilic arthropathy of the knee
Clin Orthop
(1992) - et al.
Die Lokale Vehandlung der Reumatischer Erkrankungen
Wien Inn Med
(1952) - et al.
Long-term follow-up of haemophiliac arthropathy treated by Au-198 radiation synovectomy
Int Orthop
(1993) - et al.
Radioactive synovectomy in haemophiliac haemarthrosis. Follow-up of fifty cases
Scand J Haematol
(1984)
Radioisotope synovectomy with P-32 chromic phosphate-kinetic studies
J Nucl Med
Synoviorthesis with P-32 colloidal chronic phosphate in rheumatoid arthritis: Clinical histopathological and arthrographic changes
J Rheumatol
Synoviortheses with colloidal P32 chromic phosphate for the treatment of hemophilic arthropathy
J Bone Joint Surg Am
Synovectomy of the rheumatoid knee using intra-articular injection of dysporosium 165-ferric hydroide macroaggregates
J Bone Joint Surg Am
Treatment of rheumatoid synovitis of the knee with intra-articular injection of dysprosium 165-ferric hydroide macroaggregates
Arthritis Rheum
P-32 chromic phosphate colloid radiosynovectomy for hemarthrosis and synovitis in hemophilia (abst)
Radioactive gold in the treatment of chronic synovial effusion in hemophiolia
Radioactive synoviorthesis in hemophiliac Hemarthrosis: Materials, techniques and dangers
Clin Orthop
Radiocolloids in the management of hemophiliac arthropathy in children and adolescents
Clin Orthop
Methods and results of radionucleotide synovectomies
Ort Traum Oggi
Cited by (73)
Radiochemical processing of nuclear-reactor-produced radiolanthanides for medical applications
2019, Coordination Chemistry ReviewsCitation Excerpt :The use of 165Dy (t1/2 = 2.334 h) in modern nuclear medicine is rather scarce, if not abandoned because of better available alternatives (e.g. 169Er). Examples of 165Dy being used in nuclear medicine mainly describe application in radiosynovectomy [121–126]. Joints affected by arthritis can be treated by its β− particle emission of 1.286 MeV, which has a maximum soft tissue range of 5.7 mm and a mean soft tissue range of 1.8 mm.
Reactor production and electrochemical purification of <sup>169</sup>Er: A potential step forward for its utilization in in vivo therapeutic applications
2014, Nuclear Medicine and BiologyCitation Excerpt :Radiation synovectomy (RSV), which involves intraarticular injection of beta-emitting radionuclides in colloidal or particulate form (1–10 μm size range) into the affected synovial joints, has emerged as an effective treatment modality in patients suffering from inflammatory-rheumatoid and degenerative joint diseases [1–7].
Options to meet the future global demand of radionuclides for radionuclide therapy
2013, Nuclear Medicine and BiologyCitation Excerpt :Radiolabeled particulates and microspheres have also found successful applications in treating liver cancer [27–31]. Particulates labeled with radionuclides such as 90Y, 169Er and 32P are being explored for radiosynovectomy, which is a non-cancer application [32–35]. Considering the large interest that is being generated recently in this field, it can be expected that there will be an expanding demand for therapeutic radionuclides in near future.
Synopsis of Pathophysiology in Nuclear Medicine, Second Edition
2023, Synopsis of Pathophysiology in Nuclear Medicine, Second Edition